News Report | January 26, 2020
Quadrant Biosciences Launches Clarifi ASD Saliva Test For Autism
On December 4, 2019, Quadrant Biosciences Inc. launched Clarifi ASD, the first epigenetic test to aid the diagnosis of autism spectrum disorder (ASD) in young children. The test is based on a saliva sample obtained through a mouth swab; test results are available in three to six weeks.
The test will help physicians detect autism faster, so that children with ASD can start treatment as quickly as possible. Quadrant Biosciences hopes to help change the average age of ASD diagnosis from the fifth year of life, to the second or third year of life, when early intensive behavioral intervention is . . .